发明公开
- 专利标题： IMMUNOMODULATOR
-
申请号： EP17841540.2申请日： 2017-08-17
-
公开(公告)号： EP3501519A1公开(公告)日： 2019-06-26
- 发明人: SHINKURA, Reiko , YAMAMOTO, Kota
- 申请人： National University Corporation Nara Institute of Science and Technology , Nitto Pharmaceutical Industries, Ltd.
- 申请人地址： 8916-5, Takayamacho Ikoma-shi, Nara 630-0192 JP
- 专利权人： National University Corporation Nara Institute of Science and Technology,Nitto Pharmaceutical Industries, Ltd.
- 当前专利权人： National University Corporation Nara Institute of Science and Technology,Nitto Pharmaceutical Industries, Ltd.
- 当前专利权人地址： 8916-5, Takayamacho Ikoma-shi, Nara 630-0192 JP
- 代理机构： Huenges, Martin
- 优先权： JP2016160573 20160818
- 国际公布： WO2018034318 20180222
- 主分类号： A61K31/365
- IPC分类号： A61K31/365 ; A61K31/407 ; A61K39/39 ; A61K45/00 ; A61P1/04 ; A61P11/02 ; A61P11/06 ; A61P17/00 ; A61P17/04 ; A61P27/02 ; A61P37/02 ; A61P37/08 ; A61P43/00
摘要：
The present invention provides a pharmaceutical composition to be used for the treatment or prophylaxis of allergic diseases. More specifically, the present invention provides a pharmaceutical composition to be used for the treatment or prophylaxis of allergic diseases, which contains a substance that induces selective IgA class switching in B cells. As a substance that induces selective IgA class switching in B cells, a PKC activator can be used. In addition, a composition containing a substance that induces selective IgA class switching in B cells can also be useful as a mucosal adjuvant.
信息查询
